Biogen will implement Veeva Systems’ Vault CRM platform across its global operations, the companies said on Tuesday. The decision underscores Biogen’s push to modernize commercial workflows in the pharmaceutical sector using Veeva’s cloud-based software suite.
Vault CRM, part of Veeva’s Vault CRM Suite, will serve as the technology backbone for Biogen’s commercial teams. The platform includes the Agentic Call Report, a tool designed to automate Commercial Evidence generation, streamlining compliance and operational efficiency in pharmaceutical sales and marketing.
Veeva Systems, headquartered in Pleasanton, California, provides cloud-based software tailored to life sciences, supporting more than 1,500 customers, from large pharmaceutical firms to emerging biotechnology companies. The company operates as a Public Benefit Corporation, emphasizing social and environmental impact alongside commercial objectives.
Biogen’s Senior Vice President and Global Chief Information Officer Guy Hadari said the move reflects the company’s commitment to deepening its partnership with Veeva. “We are excited to expand our strategic partnership with Veeva by moving to Vault CRM,” Hadari stated.
Veeva President and Chief Commercial Officer Tom Schwenger said the company would provide Vault CRM as the commercial foundation for Biogen’s global operations. The announcement did not disclose financial terms or a timeline for deployment.
The collaboration highlights the growing adoption of cloud-based commercial platforms in the life sciences industry, where regulatory rigor and operational scalability demand robust digital infrastructure.
